Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Eric Lipp

1-41 of 41 results

View this query on the Wikidata Query Service
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

scientific article
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

article
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

scientific article published on 17 October 2013
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

scientific article
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

scientific article published on 11 March 2016
Comprehensive Characterization of Cancer Driver Genes and Mutations

article
The genetic landscape of anaplastic astrocytoma

scientific article
Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

scientific article published on 06 June 2016
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article
Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

scientific article published on 22 September 2011
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.

scientific article
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma

scientific article published on 24 January 2013
Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

scientific article published on September 29, 2011
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma

scientific article
Outcome after bevacizumab clinical trial therapy among recurrent grade III malignant glioma patients

scientific article
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma

scientific article published on 29 May 2015
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas

scientific article published on 21 December 2017
Heterogeneity within the PF-EPN-B ependymoma subgroup

article
Phase II Study of Bevacizumab and Vorinostat for Patients with Recurrent World Health Organization Grade 4 Malignant Glioma

scientific article published on 13 November 2017
Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.

scientific article published on 12 February 2015
Association between body mass index and mortality in patients with glioblastoma mutliforme

scientific article published on September 14, 2010
Prognostic marker analysis in pediatric intracranial ependymomas

scientific article published on 07 January 2015
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma

scientific article
A cross sectional analysis from a single institution's experience of psychosocial distress and health-related quality of life in the primary brain tumor population

scientific article
Consultative issues in surgical neuropathology: a retrospective review of the rationale for submitting cases for expert review.

scientific article published on June 2015
ATCT-01PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RILOTUMUMAB AND BEVACIZUMAB (BEV) IN SUBJECTS WITH RECURRENT MALIGNANT GLIOMA (MG).

scientific article published on 9 November 2015
Adjunctive perampanel for glioma-associated epilepsy

AT-21FINAL RESULTS OF A PHASE 1 TRIAL OF AN ONCOLYTIC POLIO/RHINOVIRUS RECOMBINANT (PVSRIPO) AGAINST RECURRENT GLIOBLASTOMA (GBM).

scientific article
Tissue is the Issue: Biomarkers of Prognosis and Classification in Adult Gliomas

scientific article published on 06 November 2018
Pilot Study to Describe the Trajectory of Symptoms and Adaptive Strategies of Adults Living with Low-grade Glioma

scientific article published on 06 November 2018
The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts

scientific article published on 18 August 2020
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

scientific article published on 13 January 2021
AT-20SINGLE INSTITUTION RETROSPECTIVE REVIEW OF PERFORMANCE STATUS AND CORTICOSTEROID USE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS (PTS) TREATED ON BEVACIZUMAB (BEV).

scientific article
QL-20PROGNOSTIC IMPORTANCE OF HEALTH-RELATED QUALITY OF LIFE AND FATIGUE IN NEWLY DIAGNOSED GLIOBLASTOMA.

scientific article published in November 2014
QOL-21DIET AND HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN THE PRIMARY BRAIN TUMOR POPULATION.

scientific article
The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice

QOL-20LOW-DOSE NALTREXONE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA: PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED PILOT STUDY.

scientific article
QOL-19PROSPECTIVE EVALUATION OF CARDIOPULMONARY FITNESS IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING AN ANTI-ANGIOGENIC REGIMEN.

scientific article
Single-institution retrospective review of patients with recurrent glioblastoma treated with bevacizumab in clinical practice

QL-21SPIRITUAL WELL-BEING AND ITS ASSOCIATION WITH HEALTH-RELATED QUALITY OF LIFE IN PRIMARY BRAIN TUMOR PATIENTS.

scientific article
AT-19SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE.

scientific article

Paulina is supported by:

About Paulina

Help